VRNA

Verona Pharma
VRNA

Overview Fund Activity

28 hedge funds and large institutions have $213M invested in Verona Pharma in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 5 closing their positions.

Holders
28
Holders Change
+10
Holders Change %
+55.56%
% of All Funds
0.57%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.08%
New
15
Increased
8
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RCM
1
RA Capital Management
Massachusetts
$31.8M
2
O
2
OrbiMed
New York
$35.5M
3
NMC
3
NEA Management Company
Maryland
$31.9M
4
PA
4
Perceptive Advisors
New York
$18M
5
VC
5
Vivo Capital
California
$19M

Top Sellers

1
VP
1
venBio Partners
California
$1.24M
2
WS
2
Wedbush Securities
California
$270K
3
BBVA
3
Banco Bilbao Vizcaya Argentaria
Spain
$0
4
DADC
4
D.A. Davidson & Co
Montana
$545K
5
CCFM
5
Clear Creek Financial Management
Washington
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
$9K +$9K +1,500 New
CG
27
Cutler Group
California
$1K +$1K +200 New
Millennium Management
28
Millennium Management
New York
$68 +$68 +10,942 New
BBVA
29
Banco Bilbao Vizcaya Argentaria
Spain
– -$303K -60,000 Closed
CCFM
30
Clear Creek Financial Management
Washington
– -$175K -37,500 Closed
Renaissance Technologies
31
Renaissance Technologies
New York
– -$100K -21,410 Closed
CFD
32
Creative Financial Designs
Indiana
– -$1K -200 Closed
TRCT
33
Tower Research Capital (TRC)
New York
– -$1K -200 Closed
1
2